Skip to content

Clinical trials

Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Clear all

404 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
200110
200212
20035
200414
200514
200615
200716
200812
20099
20108
201113
201212
201310
201415
201514
201618
201712
201813
201919
202022
202115
202222
202321
202416
202511
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed183
Unknown status69
Terminated47
Recruiting47
Active, not recruiting20
Not yet recruiting18
Withdrawn17
No longer available2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology28
National Cancer Institute (NCI)25
Novartis Pharmaceuticals15
SWOG Cancer Research Network15
Fudan University12
Shanghai Pulmonary Hospital, Shanghai, China10
Radiation Therapy Oncology Group9
Wake Forest University Health Sciences8
Memorial Sloan Kettering Cancer Center7
Roswell Park Cancer Institute7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung404
Carcinoma, Non-Small-Cell Lung235
Lung Neoplasms216
Adenocarcinoma, Bronchiolo-Alveolar85
Pancreatic Neoplasms16
Neoplasm Metastasis15
Neoplasms15
Ovarian Neoplasms14
Colorectal Neoplasms13
Breast Neoplasms11

Trials

Showing 51 to 75 of 404. Each trial links to its page on Pharma Observatory.

304 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.